TES HT100 Klinisk Validering för Hjärnskadescreening hos Patienter med Lätt Hjärntrauma eller Neurologiska Symtom (TESCO)
TES HT100 Kliniska Utfall - Klinisk Validering av TES HT100 Temnograf för Hjärnskadescreening hos Patienter Med Mildt Huvudtrauma eller Misstänkta Neurologiska Symtom (TESCO)
The goal of this clinical study is to evaluate how accurately and safely the TES HT100 device can identify intracranial abnormalities in adult emergency department patients with mild head trauma or neurological symptoms that are not related to trauma and are not immediately life-threatening. The main questions it aims to answer are:
- How well does TES HT100 identify patients with intracranial abnormalities compared with head CT, the reference standard?
- Is TES HT100 safe to use in this patient population?
- Could TES HT100 help improve patient triage and use of hospital resources in the emergency setting?
Researchers will compare the result of TES HT100 with the head CT report.
Participants will:
- Be enrolled if they are adults presenting to the emergency department with mild head trauma or selected neurological symptoms
- Undergo standard clinical assessment and head CT according to usual care
- Have an additional TES HT100 examination lasting about 5 minutes, performed by trained personnel
- Be assessed for device performance and any adverse events related to use of the device
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a prospective, multicenter, open-label clinical investigation evaluating the TES HT100 as a non-invasive adjunctive screening device for detection of intracranial abnormalities in adult Emergency Department patients. The study is being conducted in three centers in Italy and Poland.
TES HT100 is intended for non-invasive detection of endocerebral lesions. The device used in this investigation is TES HT model 100, equipped with software version 1.3 or later and firmware version 1.4 or later, in the same configuration planned for commercialization. The system uses non-ionizing, ultra-low-power electromagnetic waves in the 500-6500 MHz frequency range and provides a binary result indicating the presence or absence of intracranial abnormality. The examination is brief, with an overall duration of about 5 minutes.
The study is designed to evaluate the diagnostic performance and safety of TES HT100 when used in addition to standard emergency care. Participants undergo routine clinical assessment and brain CT according to usual clinical practice, and the TES HT100 examination is performed as an add-on procedure. The reference standard for performance evaluation is the brain CT report. TES HT100 is not intended to replace standard clinical assessment or CT imaging.
To reduce interpretation bias, the TES HT100 examination is performed by trained personnel who do not have access to the CT report at the time of testing, and the radiologist interpreting the CT scan is blinded to the TES HT100 result. TES HT100 examinations are performed within 24 hours before or after CT, according to site workflow.
The investigation plans to enroll approximately 850 participants overall across two clinical cohorts. The study duration is planned to be 30 months. Three TES HT100 devices, one per participating center, will be used under the same qualification and maintenance procedures.
In addition to diagnostic validation against CT, the study includes safety monitoring during device use and an exploratory assessment of the potential clinical utility of TES HT100 in emergency department triage and resource management. The overall objective is to generate clinical evidence on the performance and safety of TES HT100 as a rapid, non-invasive screening support tool in the emergency setting.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Fabrizio Alfieri
- Telefonnummer: +39-081-19189806
- E-post: fabrizio.alfieri@temnography.com
Studieorter
-
-
CE
-
Castel Volturno, CE, Italien, 81030
- Rekrytering
- Pineta Grande Hospital
-
Kontakt:
- Dorotea Cerbarano
- Telefonnummer: +39-0823-854111
- E-post: dorotea.cerbarano@pinetagrande.it
-
Underutredare:
- Angelo Localzo, Registered Nurse
-
Underutredare:
- Esaù Russo, Registered Nurse
-
Huvudutredare:
- Adriana Modestina Conte, MD
-
Underutredare:
- Antonia Sorbo, MD - Radiologist
-
-
-
-
-
Gdansk, Polen, 80-952
- Har inte rekryterat ännu
- Emergency Department, University Clinical Centre, Medical University of Gdańsk
-
Kontakt:
- Paweł Nowicki
- Telefonnummer: +48 730 505 991
- E-post: nowicki.p@wp.pl
-
Huvudutredare:
- Mariusz Siemiński, prof. dr hab. n. med.
-
Katowice, Polen, 40-635
- Rekrytering
- Emergency Department, Leszek Giec Upper Silesian Medical Centre of the Medical University of Silesia in Katowice
-
Kontakt:
- Anna Lis, dr med.
- Telefonnummer: +48 600 198 608
- E-post: lis.anna.agn@icloud.com
-
Huvudutredare:
- Mateusz Majewski, dr n. med.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age greater than 18 years
- Provision of informed consent
- Presentation to the Emergency Department with mild head injury, or
- Presentation to the Emergency Department for non-traumatic neurological symptoms and not in a critical condition, including:
- syncope
- spatial disorientation and/or loss of balance
- speech disturbance and/or facial hemi-paresis
- visual alterations
- memory loss and/or confusional state
Exclusion Criteria:
- Age less than 18 years
- Pregnant women
- Metal plates or metal prostheses installed in the skull cap
- Severe head trauma and/or extensive lacerated-contused areas
- Critical condition
- Visible skull fracture
- Failure or inability to provide signed informed consent
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: TES HT100 Examination
All enrolled participants receive standard emergency department evaluation, including head CT according to usual clinical practice, and undergo an additional TES HT100 examination as an add-on procedure. TES HT100 is evaluated against the head CT report used as the reference standard. The study includes adults with mild head injury and adults with neurological symptoms not related to head trauma and not in a critical or life-threatening condition. |
A non-invasive, add-on diagnostic examination performed with the TES HT100 device to assess the presence or absence of intracranial abnormality in adult emergency department patients. The device uses ultra-low-power, non-ionizing electromagnetic waves in the 500-6500 MHz range and provides a binary on/off result. The examination lasts about 5 minutes, does not require direct contact with the patient's head, and is performed by trained personnel in addition to standard clinical evaluation and head CT. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Diagnostic accuracy of TES HT100 for detection of intracranial abnormalities
Tidsram: At the index emergency department visit, with TES HT100 performed within 24 hours before or after head CT
|
Diagnostic performance of TES HT100 compared with the head CT report as the reference standard, assessed by ROC-AUC and by sensitivity and specificity for identification of intracranial abnormalities. |
At the index emergency department visit, with TES HT100 performed within 24 hours before or after head CT
|
|
Rate of device-related adverse events
Tidsram: From TES HT100 examination through study participation completion, an average of 1 year
|
Incidence and type of adverse events related to the use of TES HT100 during the study. |
From TES HT100 examination through study participation completion, an average of 1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Operator time associated with TES HT100-supported screening
Tidsram: Day 1
|
Descriptive evaluation of operator time associated with use of TES HT100 during emergency department screening, based on the number of TES HT100 examinations performed per participant and the approximate duration of each examination (about 5 minutes), as described in the protocol. |
Day 1
|
|
Procedures associated with TES HT100-supported screening
Tidsram: Day 1
|
Descriptive evaluation of workflow-related procedures associated with use of TES HT100 during emergency department screening, as part of the exploratory assessment of potential clinical benefit described in the protocol. This may include patient handling or organizational procedures required during the diagnostic pathway, such as patient transfer to a different bed or room or need for additional staff support. |
Day 1
|
|
Costs associated with TES HT100-supported screening
Tidsram: Day 1
|
Descriptive evaluation of resource use and related cost considerations associated with use of TES HT100 during emergency department screening, as part of the exploratory assessment of potential clinical benefit described in the protocol. |
Day 1
|
|
Diagnostic performance of TES HT100 in predefined patient subgroups
Tidsram: At the index emergency department visit, with TES HT100 performed within 24 hours before or after head CT
|
Analysis of TES HT100 diagnostic performance, based on sensitivity and specificity versus head CT, in predefined subgroups, including younger patients, older patients, patients with or without prior injury or brain surgery, and patients with or without neurodegenerative disease. |
At the index emergency department visit, with TES HT100 performed within 24 hours before or after head CT
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Fabrizio Alfieri, B&B srl
Publikationer och användbara länkar
Allmänna publikationer
- Brazinova A, Rehorcikova V, Taylor MS, Buckova V, Majdan M, Psota M, Peeters W, Feigin V, Theadom A, Holkovic L, Synnot A. Epidemiology of Traumatic Brain Injury in Europe: A Living Systematic Review. J Neurotrauma. 2021 May 15;38(10):1411-1440. doi: 10.1089/neu.2015.4126. Epub 2018 Dec 19.
- Cuccaro A, et al. Microwave Radar Imaging as a Tool for Medical Diagnostics. Eng Proc. 2023.
- Solimene R, et al. An Incoherent Radar Imaging System for Medical Applications. IEEE CAMA 2021.
- Vaia S, Iavarone A, et al. HT temnography in the early diagnosis of brain lesions due to ischemic or hemorrhagic stroke. Int J Adv Res. 2023.
- Montemerani S, Fabrizi C, Sacchi C, Belperio A, Moriani L, Pacchi S, Garofalo C, Sbrana G, Venezia D, Zanobetti M, Nocentini S. Reliability Evaluation of Temnography for Early Detection of Intracranial Lesions in Mild Traumatic Brain Injury Patient: A Preliminary Report of a New Portable, Non-Invasive Device. Open Access Emerg Med. 2024 Dec 6;16:313-321. doi: 10.2147/OAEM.S475328. eCollection 2024.
- Islam MS, Islam MT, Almutairi AF. Experimental tissue mimicking human head phantom for estimation of stroke using IC-CF-DMAS algorithm in microwave based imaging system. Sci Rep. 2021 Nov 10;11(1):22015. doi: 10.1038/s41598-021-01486-x.
- Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol. 1996 Nov;41(11):2251-69. doi: 10.1088/0031-9155/41/11/002.
- Gabriel C, Gabriel S, Corthout E. The dielectric properties of biological tissues: I. Literature survey. Phys Med Biol. 1996 Nov;41(11):2231-49. doi: 10.1088/0031-9155/41/11/001.
- Lefevre-Dognin C, Cogne M, Perdrieau V, Granger A, Heslot C, Azouvi P. Definition and epidemiology of mild traumatic brain injury. Neurochirurgie. 2021 May;67(3):218-221. doi: 10.1016/j.neuchi.2020.02.002. Epub 2020 May 6.
- Mckee AC, Daneshvar DH. The neuropathology of traumatic brain injury. Handb Clin Neurol. 2015;127:45-66. doi: 10.1016/B978-0-444-52892-6.00004-0.
- Conte AM, Alfieri F, Localzo A, Russo E, Cucinotto I, Trovato A, Gualtieri R, Laccetti E, Sorbo A. Prospective blinded interim evaluation of a portable radiofrequency device TES HT to support triage in emergency department patients with mild head trauma or acute neurological symptoms. BMC Emerg Med. 2026 Jul 7. doi: 10.1186/s12873-026-01676-8. Online ahead of print.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Hjärnskador, traumatiska
- Hjärnsjukdomar
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Sår och skador
- Patologiska processer
- Sjukdomsegenskaper
- Trauma, nervsystemet
- Huvudskador, stängt
- Sår, Icke-penetrerande
- Patologiska tillstånd, tecken och symtom
- Nödsituationer
- Hjärnskador
- Hjärnskakning
- Kraniocerebralt trauma
Andra studie-ID-nummer
- CLV-01-TES HT
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
De-identified participant-level data may be shared upon reasonable request, subject to ethics and institutional approval where applicable and execution of a data sharing agreement. Public sharing is not planned due to confidentiality and consent restrictions.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .